Brazil · Delayed Price · Currency is BRL Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of BRL 1.49 trillion. The enterprise value is 1.68 trillion.
| Market Cap | 1.49T |
| Enterprise Value | 1.68T |
Important Dates
The next estimated earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Mar 13, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.34% |
| Shares Change (QoQ) | -0.40% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 80.12% |
| Float | 2.47B |
Valuation Ratios
The trailing PE ratio is 14.84 and the forward PE ratio is 22.18.
| PE Ratio | 14.84 |
| Forward PE | 22.18 |
| PS Ratio | 4.17 |
| PB Ratio | 5.14 |
| P/TBV Ratio | 62.33 |
| P/FCF Ratio | 21.92 |
| P/OCF Ratio | 16.44 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.78, with an EV/FCF ratio of 24.71.
| EV / Earnings | 16.73 |
| EV / Sales | 4.90 |
| EV / EBITDA | 10.78 |
| EV / EBIT | 13.01 |
| EV / FCF | 24.71 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.
| Current Ratio | 1.54 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 1.71 |
| Debt / FCF | 4.09 |
| Interest Coverage | 18.03 |
Financial Efficiency
Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 25.91%.
| Return on Equity (ROE) | 36.88% |
| Return on Assets (ROA) | 12.04% |
| Return on Invested Capital (ROIC) | 25.91% |
| Return on Capital Employed (ROCE) | 22.54% |
| Weighted Average Cost of Capital (WACC) | 5.17% |
| Revenue Per Employee | 4.84M |
| Profits Per Employee | 1.36M |
| Employee Count | 74,000 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.32 |
Taxes
In the past 12 months, Merck & Co. has paid 15.44 billion in taxes.
| Income Tax | 15.44B |
| Effective Tax Rate | 13.31% |
Stock Price Statistics
The stock price has increased by +15.82% in the last 52 weeks. The beta is 0.26, so Merck & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +15.82% |
| 50-Day Moving Average | 75.41 |
| 200-Day Moving Average | 63.34 |
| Relative Strength Index (RSI) | 45.09 |
| Average Volume (20 Days) | 2,809 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.66 |
Income Statement
In the last 12 months, Merck & Co. had revenue of BRL 358.08 billion and earned 100.54 billion in profits. Earnings per share was 40.10.
| Revenue | 358.08B |
| Gross Profit | 276.48B |
| Operating Income | 134.76B |
| Pretax Income | 116.04B |
| Net Income | 100.54B |
| EBITDA | 160.31B |
| EBIT | 134.76B |
| Earnings Per Share (EPS) | 40.10 |
Balance Sheet
The company has 80.22 billion in cash and 278.34 billion in debt, with a net cash position of -198.12 billion.
| Cash & Cash Equivalents | 80.22B |
| Total Debt | 278.34B |
| Net Cash | -198.12B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 290.06B |
| Book Value Per Share | 117.09 |
| Working Capital | 83.66B |
Cash Flow
In the last 12 months, operating cash flow was 90.73 billion and capital expenditures -22.65 billion, giving a free cash flow of 68.08 billion.
| Operating Cash Flow | 90.73B |
| Capital Expenditures | -22.65B |
| Depreciation & Amortization | 24.64B |
| Net Borrowing | 60.45B |
| Free Cash Flow | 68.08B |
| FCF Per Share | n/a |
Margins
Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.
| Gross Margin | 77.21% |
| Operating Margin | 37.64% |
| Pretax Margin | 32.41% |
| Profit Margin | 28.08% |
| EBITDA Margin | 44.77% |
| EBIT Margin | 37.64% |
| FCF Margin | 19.01% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.99%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 1.99% |
| Dividend Growth (YoY) | -2.24% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 3.75% |
| Buyback Yield | 1.34% |
| Shareholder Yield | 3.35% |
| Earnings Yield | 6.74% |
| FCF Yield | 4.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 29, 2020. It was a forward split with a ratio of 8.
| Last Split Date | Oct 29, 2020 |
| Split Type | Forward |
| Split Ratio | 8 |
Scores
Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.5 |
| Piotroski F-Score | 5 |